Additional file 1 of Results of the preclinical multicenter randomized controlled paclitaxel-induced neuropathy prevention replication study (PINPRICS)
Drug combinations are becoming a standard treatment of many complex diseases due to their capability to overcome resistance to monotherapy. In the current preclinical drug combination screening, the t
Additional file 1. Materials, Methods, and Abbreviations. Figure S1. Gating strategy of DCs and representative histograms of the surface markers. Figure S2. Immunophenotypes of mouse T cells. Figure S
This data was obtained from the study aimed at determining changes in parasitaemia and selected liver and kidney function parameters in NK 65 Plasmodium berghei passaged mice treated with oral coadmin
Background: Cisplatin is a common and effective chemotherapeutic agent used to treat various cancers. However, it has a dose-limiting effect, resulting in chemotherapy-induced peripheral neuropathy (C